NCT00602342View on ClinicalTrials.gov

Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Onychomycosis
Interventions
DRUG

Terbinafine

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602342 - Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter